4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Daré Bioscience, Inc. (DARE) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 21 employees. Its market capitalization is roughly $31 million. In the fiscal year ended 2025-12-31, DARE reported $1M in revenue and ($13M) in net income.
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis.
Interactive charts & full statements → Open the DARE valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $0M | $3M | $10M | — |
| Gross Profit | $1M | — | — | — | — |
| Operating Income (EBIT) | ($14M) | ($24M) | ($31M) | ($31M) | — |
| Net Income | ($13M) | ($4M) | ($30M) | ($31M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $1M | $0M | $0M | $0M | — |
| Gross Profit | ($0M) | $1M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($3M) | ($2M) | ($4M) | ($4M) | ($5M) | — |
| Net Income | ($3M) | ($1M) | ($4M) | ($4M) | ($4M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $32M | $22M | $21M | $44M | — |
| Total Liabilities | $30M | $28M | $26M | $33M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DARE viewer.
About TickerBase · Data methodology & sources